Darrick Carter has founded and led five biotechnology companies since 2001. Upon receiving his PhD from the Oregon Health Sciences Center, he joined Corixa Corporation where he led a new tuberculosis vaccine into human clinical trials. He is an inventor/co-inventor on more than 160 patent applications and issued patents. In 2005, he founded the bioinformatics company Protein Advances Inc. Darrick sits on the Advisory Boards of three biotechs.

Richard Herman is an experienced leader in the discovery and development of biotechnology products. After receiving his PhD from the Univ. of Minnesota, he joined BioTechnique Laboratories and led their microbial research efforts. He then served in leadership positions at Phage Therapeutics and later Nastech Pharmaceuticals. Most recently, he directed pharmaceutical development at Viridax, an early stage startup focused on anti-microbials.

David Pritchard has 13 years of experience developing tools to analyze complex datasets. After receiving his PhD from the Univ. of Washington, he joined LifeSpan Biosciences where he developed computer programs to facilitate antibody production, data set analysis tools, and tools to automatically parse pathology reports. Most recently, he directed a microarray core analysis facility at the Univ. of Washington.

Jason Wooden has broad experience in technology and product development. After completing his PhD at the Univ. of Washington, he joined Procter & Gamble where he served on the Metamucil® marketing claims team. He later helped restart the GI technology pipeline and facilitated early work for Align®, a novel treatment for IBS. Most recently, he worked at the Puget Sound Blood Center on developing a diagnostic test for red blood cell diseases.